Equities

Sotac Pharmaceuticals Ltd

Sotac Pharmaceuticals Ltd

Actions
  • Price (INR)150.00
  • Today's Change0.00 / 0.00%
  • Shares traded1.20k
  • 1 Year change+22.95%
  • Beta--
Data delayed at least 15 minutes, as of Sep 17 2024 04:47 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of INR
(except for per share items)
Fiscal data as of Mar 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue580732488
OPERATING EXPENSES
Cost of revenue total401560394
Selling, general and admin. expenses, total293432
Depreciation/amortization161126
Unusual expense(income)--18--
Other operating expenses, total685848
Total operating expense514681500
Operating income6650(11)
Other, net1.451.810.78
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes6047(21)
Provision for income taxes15183.09
Net income after taxes4529(24)
Minority interest------
Net income before extra. Items4529(24)
Total extraordinary items------
Net income4529(24)
Inc.avail. to common excl. extra. Items4529(24)
Inc.avail. to common incl. extra. Items4529(24)
EPS RECONCILIATION
Basic/primary weighted average shares8.061111
Basic/primary eps excl. extra items5.582.61(2.14)
Basic/primary eps incl. extra items5.582.61(2.14)
Dilution adjustment------
Diluted weighted average shares8.061111
Diluted eps excl. extra items5.582.61(2.14)
Diluted eps incl. extra items5.582.61(2.14)
COMMON STOCK DIVIDENDS
DPS - common stock primary issue------
Gross dividend - common stock------
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental7.644.959.96
SUPPLEMENTAL INCOME
Depreciation, supplemental161126
Total special items--18--
NORMALISED INCOME
Normalized income before taxes6065(21)
Effect of special items on income taxes--7.10--
Income tax excluding impact of special items15253.09
Normalized income after tax4540(24)
Normalized income avail. to common4540(24)
Basic normalized EPS5.583.62(2.14)
Diluted normalized EPS5.583.62(2.14)
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.